Cargando…
The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis
AIMS: This study aimed to assess the impact of different antidiabetic agents on individuals with diabetes and COVID-19. METHODS: We searched PubMed, Web of Science, Embase, and Cochrane Library databases from inception to October 31, 2021 and included seven antidiabetic agents. The data were pooled...
Autores principales: | Chen, Yidan, Lv, Xingfei, Lin, Sang, Arshad, Mohammad, Dai, Mengjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186017/ https://www.ncbi.nlm.nih.gov/pubmed/35692410 http://dx.doi.org/10.3389/fendo.2022.895458 |
Ejemplares similares
-
Effects of Antidiabetic Drugs on Endothelial Function in Patients With Type 2 Diabetes Mellitus: A Bayesian Network Meta-Analysis
por: Wang, Yuhan, et al.
Publicado: (2022) -
Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
por: Kan, Chengxia, et al.
Publicado: (2021) -
Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
por: Zhao, Li-Min, et al.
Publicado: (2022) -
Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: a protocol for network meta-analysis
por: Jia, Yongliang, et al.
Publicado: (2015) -
Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses
por: Deng, Jiawen, et al.
Publicado: (2020)